Loading...

Amneal Pharmaceuticals, Inc.

AMRX•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$12.52
$-0.13(-1.03%)
U.S. Market opens in NaNh NaNm

Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview

Explore Amneal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4B
P/E Ratio93.23
EPS (TTM)$0.22
ROE-0.42%
Fundamental Analysis

AI Price Forecasts

1 Month$12.74
3 Months$17.27
1 Year Target$15.24

AMRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amneal Pharmaceuticals, Inc. (AMRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 93.23 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.03%
5-Day Change
-7.05%
1-Month Change
3.73%
3-Month Change
-6.50%
6-Month Change
18.67%
Year-to-Date (YTD) Change
-0.63%
1-Year Change
68.73%
3-Year Change
615.43%
5-Year Change
113.29%
All-Time (Max) Change
163.58%

Contact Information

https://www.amneal.com
908 947 3120
400 Crossing Boulevard, Bridgewater, NJ, 08807

Company Facts

8,300 Employees
IPO DateMay 7, 2018
CountryUS
Actively Trading

Frequently Asked Questions